Rockwell Medical (NASDAQ: RMTI) announced Monday that Stuart Paul has resigned as president and CEO. Paul, who has held the company’s top executive post since 2018, has also stepped down from the Wixom, MI-based company’s board of directors. No reason was given for the resignation.
Russell Ellison, who joined Rockwell Medical’s board in January, was named the new president and CEO. He will also continue to serve on the company’s board. Ellison’s previous experience includes CEO roles at Promedior, Bond Biosciences, and Assembly Biosciences (NASDAQ: ASMB). Rockwell Medical develops products to treat end-stage renal disease and chronic kidney disease.